Humanwell Healthcare (Group) Co.,Ltd.

Equities

600079

CNE000000QW6

Pharmaceuticals

End-of-day quote Shanghai S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
19.35 CNY -0.51% Intraday chart for Humanwell Healthcare (Group) Co.,Ltd. -4.02% -22.16%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
China Approves Sale of Humanwell Healthcare Unit's Prostate Cancer Treatment MT
Humanwell Healthcare's Subsidiary Gets Nod to Register Idecalcidol Soft Capsules MT
Production Line of Humanwell Healthcare's Unit Passes UK Drug Regulator's Inspection MT
Humanwell Healthcare's Subsidiary Gets Nod to Register Anesthesia Drug MT
Humanwell Healthcare's Unit Enters Phase II Trial of Gout Drug MT
Humanwell Unit Gets China Registration Certificate for Drug to Prevent Renal Allograft Rejection MT
Humanwell Healthcare Gets Registration Approval for Pain Medication MT
Humanwell Healthcare Co.,Ltd. signed an agreement essential business operations of PAION AG and PAION Deutschland GmbH. CI
Humanwell Healthcare's Unit Gets Nod for Registration of Acetaminophen Mannitol Injection MT
Humanwell Healthcare's Unit to Trial Naltrexone Bromide Tablets MT
Humanwell Healthcare Registers Anesthesia Drug MT
Humanwell Healthcare Registers Blood Clot Drug MT
Humanwell Healthcare Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Humanwell Healthcare's Unit Gets Nod to Trial HZ-J001 Cream MT
Humanwell Healthcare Completes Transfer of Huatai Insurance Stake MT
Humanwell Healthcare's Unit Gets FDA's Tentative Approval for Gabapentin Tablets MT
Humanwell Healthcare’s Prostate Cancer Drug Secures Tentative US FDA Nod MT
Humanwell Healthcare Unit Gets Registration Certificate for Azithromycin Dry Suspension MT
Humanwell Healthcare's Unit Gets Nod to Trial HWH486 Capsules MT
Humanwell Healthcare Registers Treatment Against Lung Diseases MT
Humanwell Healthcare Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Humanwell Healthcare’s Controlling Shareholder Faces Regulatory Probe MT
Humanwell Healthcare's Unit Gets Nod to Register Febuxostat Tablets MT
China Launches National Platform for Computing Power Scheduling With China Telecom MT
Humanwell Healthcare Gets Nod for Antifungal Drug's Registration MT
Chart Humanwell Healthcare (Group) Co.,Ltd.
More charts
Humanwell Healthcare (Group) Co., Ltd is a China-based company principally engaged in research and development, manufacture and distribution of medical and pharmaceutical products. The Company's products are categorized into chemical drugs, chemical raw material medicines, traditional Chinese medicines, biological medicines and others. The Company also provides medical instruments. The Company distributes its products in both domestic market and to overseas markets.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
19.35
Average target price
-
Consensus
  1. Stock
  2. Equities
  3. Stock Humanwell Healthcare (Group) Co.,Ltd. - Shanghai S.E.
  4. News Humanwell Healthcare (Group) Co.,Ltd.
  5. Humanwell Healthcare to Sell Entire RiteDose Stake For $174 Million; Shares Jump 3%